Filing Details

Accession Number:
0001209191-17-028285
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-27 08:06:38
Reporting Period:
2017-04-26
Filing Date:
2017-04-27
Accepted Time:
2017-04-27 08:06:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080709 Arena Pharmaceuticals Inc ARNA Pharmaceutical Preparations (2834) 232908305
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612551 Amit Munshi C/O Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego CA 92121
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-31 625 $1.24 1,875 No 5 J Direct
Common Stock Acquisiton 2017-04-26 50,000 $1.41 51,875 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 J Direct
No 4 P Direct
Footnotes
  1. These shares were acquired pursuant to the 2009 Arena Employee Stock Purchase Plan.